The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Ferrero B, Rivoiro C, Ferrero C, Picco E, Ripellino P, Viglietti D, Giuliani G, Montanari E, Clerico M; OPTIMS Study Group.
Durelli L, et al.
J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.
J Neurol. 2008.
PMID: 18825438
Clinical Trial.